The lacrimal gland is a small, almond-shaped organ tucked into the upper outer corner of each eye socket, and its primary job is producing the watery layer of your tears. Despite its modest size, this gland orchestrates a surprisingly complex operation involving nerve signals, hormones, immune defense proteins, and even a built-in circadian clock. When it stops working properly, the consequences range from chronic dry eye to severe autoimmune damage.
Where It Sits and How It Is Built
Each lacrimal gland sits in a shallow depression in the frontal bone of the skull, just behind the outer rim of your eye socket. A thin sheet of connective tissue from the muscle that lifts your upper eyelid divides the gland into two sections: a larger orbital lobe deeper in the socket, and a smaller palpebral lobe closer to the surface, just above the upper eyelid. Tear fluid drains from both lobes through a series of small ducts that open into the upper fold of the conjunctiva, the membrane lining the inside of your eyelid. From there, each blink spreads tears across the cornea.
The blood supply follows a predictable pattern. The main lacrimal artery runs along the edge of the connective tissue sheet between the two lobes, sending two branches into each lobe. Detailed imaging using micro-CT scanning has mapped these internal vessels, showing well-defined branches reaching throughout both the orbital and palpebral portions of the gland.1PubMed. Internal vascular anatomy of the human lacrimal gland: A protocol based on cadaver dissection and three-dimensional micro-computed tomography This blood supply is generous relative to the gland’s size, which makes sense given how metabolically active secretory tissue needs to be.
The Cells That Make Tears
Under a microscope, the lacrimal gland looks like a cluster of tiny sacs (acini) connected by a branching system of ducts. Three main cell types do the work. Acinar cells are the real factories, producing the proteins and watery fluid that make up the bulk of your tears. Ductal cells line the drainage channels and modify the fluid as it passes through, adjusting its salt and water content. The third type, myoepithelial cells, wraps around the outside of the acini like a mesh of tiny muscle fibers. These cells can contract, squeezing the acini to help push freshly made tear fluid out through the ducts.2PubMed Central. Myoepithelial Cells: Their Origin and Function in Lacrimal Gland Morphogenesis, Homeostasis, and Repair
Myoepithelial cells are an interesting hybrid. They have the contractile ability of smooth muscle cells but also carry molecular markers typical of epithelial (surface-lining) cells. This dual identity makes them important not just for squeezing tears out of the gland, but also for maintaining the gland’s structural integrity and potentially for repair after injury.
What Is Actually in Your Tears
Tear fluid is far more than salt water. The lacrimal gland secretes water, electrolytes, and a cocktail of proteins that serve distinct purposes. Among the most abundant proteins are lactoferrin and lysozyme, both of which have antimicrobial properties. They act as a first line of immune defense on the surface of your eye, killing or inhibiting bacteria and other pathogens before they can gain a foothold.
Research has found that the levels of these antimicrobial proteins can fluctuate meaningfully. People who developed confirmed upper respiratory tract infections had lower tear lysozyme concentrations and lower secretion rates of both lysozyme and lactoferrin compared to healthy controls. Contact lens wearers also showed lower antimicrobial protein secretion rates. Even vigorous exercise caused a temporary dip, with secretion rates dropping roughly 42 to 49 percent in the first hour after a workout compared to baseline.3PubMed Central. Tear Lactoferrin and Lysozyme as Clinically Relevant Biomarkers of Mucosal Immune Competence These shifts suggest that tear composition is a dynamic readout of your immune status, not a fixed product.
The electrolyte transport that generates the watery component of tears is itself a carefully choreographed process. Acinar cells pump chloride ions across their membranes through specific channels, pulling water along by osmosis. The machinery involved includes sodium-potassium pumps and multiple ion exchangers on different sides of the cell, all working together to move fluid in one direction, from the blood side to the tear side.4PubMed. Lacrimal fluid and electrolyte secretion: a review
How Your Nerves Control Tear Production
You do not consciously decide to produce tears. The lacrimal gland is under the control of your autonomic nervous system, the same branch of your nervous system that manages heart rate, digestion, and other involuntary functions. The process starts at the surface of the eye: sensory nerve endings in the cornea and conjunctiva detect dryness, irritation, or other stimuli and relay signals to the brain. The brain then sends commands back through parasympathetic and sympathetic nerves that directly contact the gland, triggering the release of neurotransmitters that cause acinar cells to secrete water, electrolytes, and proteins.5PubMed Central. Neural regulation of lacrimal gland secretory processes: relevance in dry eye diseases
For years, researchers debated how much each branch of the autonomic system contributed. Recent work has largely settled this. When investigators severed the postganglionic nerves supplying the lacrimal gland in mice, both basal tearing and reflex tearing dropped dramatically. Continuous infusion of sympathetic-system drugs after denervation did not restore tear secretion or prevent gland shrinkage. But infusing a parasympathetic receptor activator did increase tearing and slowed the gland’s deterioration.6PubMed. Identification of Lacrimal Gland Postganglionic Innervation and Its Regulation of Tear Secretion The takeaway: the parasympathetic nervous system is the dominant driver of tear secretion. Sympathetic nerves are present and release their own neurotransmitters, but they play a much smaller role in keeping the gland functioning.7The American Journal of Pathology. Lacrimal Gland Postganglionic Innervation: Unveiling the Role of Parasympathetic and Sympathetic Nerves in Stimulating Tear Secretion
This has practical implications. Medications with anticholinergic effects (which block parasympathetic signaling) are well known to cause dry eyes as a side effect. Antihistamines, certain antidepressants, and bladder control drugs all fall into this category. Understanding that parasympathetic input is essentially the gland’s on switch explains why these drugs reduce tear production so reliably.
Hormones and Sex Differences
Dry eye disease is considerably more common in women, particularly after menopause, and sex hormones are part of the reason. The human lacrimal gland expresses receptors for androgens, estrogen-alpha, and estrogen-beta. Interestingly, estrogen receptor alpha is the most abundantly expressed of the three, and there is no significant difference in receptor expression between men and women at the mRNA level.8PubMed Central. Expression of Androgen and Estrogen Receptors in the Human Lacrimal Gland
That finding is somewhat surprising, because much of the earlier research pointed to androgens as the critical hormone. Mouse studies have shown that testosterone regulates over 2,000 genes in the lacrimal gland, affecting everything from cell growth and metabolism to signal transduction. The effect appears to work through androgen receptors directly regulating gene transcription.9PubMed. Androgen regulation of gene expression in the mouse lacrimal gland The implication is that when androgen levels decline, whether through aging, menopause, or anti-androgen medications, the gland loses a broad layer of hormonal support that keeps it functioning at full capacity. The higher prevalence of dry eye in postmenopausal women likely reflects this withdrawal of hormonal input, though the relationship between estrogen, androgens, and lacrimal function is still being untangled.
A Built-In Tear Clock
If you have ever noticed that your eyes feel drier at certain times of day, there is a biological explanation. The lacrimal gland has its own internal circadian clock. In mice, tear secretion follows a clear daily rhythm, with tear volume peaking during the active phase (nighttime for nocturnal mice). This rhythm persists even in constant darkness, confirming it is driven by an internal clock rather than just a response to light. Clock genes in the gland oscillate in a regular pattern, and when those genes are knocked out, the daily rhythm of tear secretion disappears.10PubMed. Circadian clock regulates tear secretion in the lacrimal gland
For humans, whose active phase is daytime, this likely means tear production ramps up during waking hours and dips overnight, which aligns with the common experience of mild eye dryness upon waking. Disrupted sleep patterns, shift work, or jet lag could plausibly throw this rhythm off, though direct human data on that question are still limited.
How the Gland Forms Before Birth
The lacrimal gland starts developing around the seventh week of human gestation as a small bud of tissue that grows outward from the conjunctival surface. It then undergoes branching morphogenesis, a process where a simple tube-like structure divides and subdivides into the complex, tree-like network of ducts and acini that the mature gland needs.
Several signaling pathways guide this branching. FGF (fibroblast growth factor) signaling promotes growth and branching, working partly through a pair of genes called Sox9 and Sox10.11Development. FGF signaling activates a Sox9-Sox10 pathway for the formation and branching morphogenesis of mouse ocular glands The Wnt signaling pathway, on the other hand, acts as a brake. When Wnt signaling is artificially boosted, growth and branching slow down; when it is reduced, branching accelerates. This push-and-pull between FGF (go) and Wnt (stop) ensures the gland develops the right degree of complexity without overgrowing.12PubMed. Canonical Wnt signaling negatively regulates branching morphogenesis of the lung and lacrimal gland The same balance operates during lung development, which is why researchers sometimes study both organs in parallel.
What Aging Does to the Gland
Like most organs, the lacrimal gland deteriorates with age, and the effects compound. In aging mouse models, one of the earliest changes is a decline in the neural stimulation of protein secretion. Even before the tissue looks overtly damaged, the signaling pathway from nerve to acinar cell starts losing efficiency. Alongside this, mast cells accumulate in the gland, and lipofuscin, an age-related cellular waste product, builds up. At more advanced ages, elevated blood sugar and increased infiltration by immune cells contribute further to declining function.13PubMed Central. The aging lacrimal gland: changes in structure and function
Oxidative stress appears to be a major accelerator of this process. In mice engineered to lack a key antioxidant enzyme (superoxide dismutase 1), lacrimal glands develop pronounced acinar atrophy, fibrosis, and infiltration with immune cells including T cells, monocytes, and neutrophils. Markers of oxidative DNA damage and cell death increase significantly.14The American Journal of Pathology. Oxidative Stress–Induced Lacrimal Gland Dysfunction in a Mouse Model of Age-Related Dry Eye The implication is that the gland’s decline with age is not just wear and tear but an active process driven partly by the accumulation of reactive oxygen species damaging cellular components.
Autoimmune Attack and Sjögren’s Syndrome
The most well-known disease of the lacrimal gland is Sjögren’s syndrome, an autoimmune condition in which the immune system targets moisture-producing glands throughout the body. The lacrimal gland and salivary glands take the worst of it, leading to severely dry eyes and dry mouth. The destruction is driven primarily by T cells, particularly those producing the inflammatory cytokine interferon-gamma. In mouse models of the disease, interferon-gamma is critical for glandular destruction and the resulting loss of secretory function. When the balance between interferon-gamma and the anti-inflammatory cytokine IL-13 tips too far toward the inflammatory side, glandular cell death accelerates.15PubMed Central. Altered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjögren’s syndrome
One unexpected finding from this field involves gut bacteria. In a Sjögren’s mouse model, animals raised in completely germ-free conditions (no gut microbiome at all) developed worse lacrimal gland inflammation than those housed in normal conditions. The germ-free mice had greater corneal barrier dysfunction, fewer protective goblet cells, and more aggressive T cell infiltration of the gland.16PubMed Central. Protective role of commensal bacteria in Sjögren Syndrome This suggests that a healthy microbiome produces metabolites or immune signals that help restrain the autoimmune attack on the lacrimal gland, a finding with potential therapeutic implications for fecal microbiota-based treatments.
Another inflammatory condition, IgG4-related dacryoadenitis, causes the lacrimal gland to swell dramatically. Unlike Sjögren’s, this involves a specific type of antibody-producing cell infiltrating the gland. Biopsies characteristically show dense collections of IgG4-positive plasma cells and a distinctive pattern of scarring called storiform fibrosis.17PubMed Central. IgG4-Related Dacryoadenitis in Egyptian Patients: A Retrospective Study The condition responds well to corticosteroids in most cases, distinguishing it from Sjögren’s, which is harder to treat.
Tumors of the Lacrimal Gland
Lacrimal gland tumors are rare but diagnostically tricky because several distinct tumor types arise here, each with different behavior and prognosis. The most common benign tumor is pleomorphic adenoma, a slow-growing mass that can recur if incompletely removed. On the malignant side, adenoid cystic carcinoma is the most feared, known for its tendency to invade along nerves and recur years after initial treatment.
Genetic analysis of these tumors has revealed characteristic molecular signatures. The majority of adenoid cystic carcinomas express a specific fusion gene (MYB-NFIB) or carry rearrangements of the MYB gene, along with recurrent losses on chromosomes 6q, 12q, and 17q. Pleomorphic adenomas express a different marker, PLAG1, in essentially all cases. Mucoepidermoid carcinoma, a rarer malignancy, carries yet another fusion gene (CRTC1-MAML2), which appears to be specific to lacrimal gland mucoepidermoid carcinoma.18PubMed. Tumours of the lacrimal gland. Epidemiological, clinical and genetic characteristics These molecular differences matter clinically because they can help pathologists distinguish between tumor types when the tissue appearance alone is ambiguous, and they may eventually guide targeted treatment strategies.
How Doctors Evaluate the Gland
When a clinician suspects lacrimal gland problems, the evaluation usually begins with a Schirmer test, a simple strip of filter paper placed under the lower eyelid to measure tear production over five minutes. But imaging is increasingly used to assess the gland itself, particularly in suspected Sjögren’s syndrome.
Ultrasound and MRI can both detect structural changes in the gland. A systematic review found that glandular heterogeneity on ultrasound had over six times the odds of being associated with Sjögren’s-affected glands compared to healthy ones. On MRI, reduced diffusion and heterogeneity were characteristic features. Somewhat frustratingly, ultrasound parameters did not reliably distinguish between Sjögren’s patients who had dry eye symptoms and those who did not, which limits its usefulness as a functional test.19PubMed Central. Radiological Imaging of the Lacrimal Gland in Sjogren’s Syndrome: A Systematic Review and Meta-Analysis
A newer approach, shear-wave elastography, measures the stiffness of the gland tissue. Patients with low tear production (Schirmer values below 10 mm) had significantly stiffer lacrimal glands than healthy controls, even in the absence of Sjögren’s syndrome. This stiffness likely reflects fibrotic changes in underperforming glands and could become a useful add-on tool for diagnosing and monitoring dry eye disease.20PubMed. Evaluation of Main Lacrimal Gland through Shear-wave Ultrasound Elastography in Patients with Low Schirmer Value
Treatments and Regenerative Research
Current treatment for lacrimal gland insufficiency mostly works around the problem rather than fixing it. Artificial tears replace missing fluid. Anti-inflammatory eye drops like cyclosporine and lifitegrast calm the surface inflammation that dry eyes provoke. Secretagogues, drugs that stimulate whatever functional gland tissue remains, represent a more direct approach. Diquafosol tetrasodium, for example, is approved in several countries and works by activating purinergic receptors on the eye surface to boost both water and mucin secretion.21PubMed. Lacrimal Gland Insufficiency in Aqueous Deficiency Dry Eye Disease: Recent Advances in Pathogenesis, Diagnosis, and Treatment Older lab work demonstrated that certain compounds related to bromhexine (a mucolytic drug) could stimulate protein secretion from lacrimal gland cells in a dose-dependent manner, acting through sigma receptors.22PubMed. Lacrimal secretion stimulants: sigma receptors and drug implications
The most exciting frontier, though, is regeneration. Researchers have succeeded in growing three-dimensional lacrimal gland organoids, miniature gland-like structures cultured in the lab from both mouse and human tissue. These organoids can be maintained for months, they resemble the duct structures of a real gland, and they respond to neurotransmitters by producing tear-like secretions. When transplanted into the eye socket of a mouse, human organoids engrafted and produced mature tear components.23Cell Stem Cell. Long-term expansion of 3D lacrimal gland organoids from mice and humans This technology is still in early stages, but it opens the door to eventually replacing a damaged lacrimal gland with lab-grown tissue, which would be a fundamental shift from managing symptoms to curing the underlying problem.24PubMed. Advances in lacrimal gland organoid development: Techniques and therapeutic applications
Smoking and Environmental Oxidative Stress
The lacrimal gland does not exist in a vacuum, and environmental exposures can damage it directly. In rats exposed to mainstream cigarette smoke, the lacrimal gland showed clear signs of dysfunction. Smoke exposure triggered upregulation of a detoxification enzyme (CYP1A1) in the gland’s duct cells, which in turn generated reactive oxygen species. These free radicals caused oxidative DNA damage within the gland tissue, detected by elevated levels of 8-hydroxy-2′-deoxyguanosine, a specific marker of that type of injury.25Free Radical Biology and Medicine. Corneal damage and lacrimal gland dysfunction in a smoking rat model The cornea showed parallel damage, suggesting that smoking hits the tear system from both sides: it degrades the gland that produces tears and damages the surface those tears are supposed to protect.
This fits with the broader pattern emerging from aging research. Oxidative stress is a common thread linking age-related gland decline, environmental toxin exposure, and even some autoimmune damage. The gland’s high metabolic rate, necessary for continuous tear production, may make it particularly vulnerable to oxidative insults. For anyone experiencing chronic dry eyes, smoking is one modifiable risk factor with a plausible biological mechanism linking it directly to lacrimal gland damage, not just general irritation of the eye surface.